产品: ATF3 抗体
货号: DF3110
描述: Rabbit polyclonal antibody to ATF3
应用: WB IHC IF/ICC
文献验证: WB, IHC
反应: Human, Mouse, Rat
预测: Pig, Bovine, Horse, Sheep, Rabbit, Dog, Chicken, Xenopus
蛋白号: P18847
RRID: AB_2835487

浏览相似产品>>

   规格 价格 库存
 50ul RMB¥ 1250 现货
 100ul RMB¥ 2300 现货
 200ul RMB¥ 3000 现货

货期: 当天发货

联系销售

产品描述

来源:
Rabbit
应用:
WB 1:500-1:1000, IF/ICC 1:100-1:500, IHC 1:50-1:200
*The optimal dilutions should be determined by the end user. For optimal experimental results, antibody reuse is not recommended.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human, Mouse, Rat
克隆:
Polyclonal
特异性:
ATF3 Antibody detects endogenous levels of total ATF3.
RRID:
AB_2835487
引用格式: Affinity Biosciences Cat# DF3110, RRID:AB_2835487.
偶联:
Unconjugated.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

Activating transcription factor 3; ATF3; ATF3_HUMAN; ATF3deltaZip2; ATF3deltaZip2c; ATF3deltaZip3; cAMP dependent transcription factor ATF3; cAMP-dependent transcription factor ATF-3; Cyclic AMP dependent transcription factor ATF3; Cyclic AMP-dependent transcription factor ATF-3;

抗原和靶标

免疫原:

A synthesized peptide derived from human ATF3, corresponding to a region within C-terminal amino acids.

基因/基因ID:

研究领域

· Human Diseases > Infectious diseases: Viral > HTLV-I infection.

文献引用

1). Piezo1 Upregulation in Monocyte-Derived Macrophages Impairs Post-Myocardial Infarction Cardiac Repair via Defective Efferocytosis and Enhanced Ferroptosis. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025 (PubMed: 41214880) [IF=15.1]

Application: WB    Species: Mouse    Sample:

Figure 6 Piezo1 increased SLC7A11 in a Ca2+/ATF4-dependent manner and increased SLC15A3 in a Ca2+-dependent manner in macrophages. A) Heatmap of the genes of interest (the same as the 17 genes that were upregulated and the 17 genes that were downregulated by Yoda1 shown in Figure 5) identified by a new RNA-seq analysis of Piezo1fl/fl and Piezo1Lyz2 BMDMs, which were treated with DMSO or Yoda1 (5 µm) for 12 h. B) Levels of Atf4, Atf3, Nrf2 and P53 mRNAs in BMDMs after treatment with DMSO or Yoda1 (n = 6). C,D) Representative Western blots and quantification of the protein levels of ATF4, ATF3, NRF2 and P53 in BMDMs (n = 3). E) Representative images of immunofluorescence staining showing the ATF4 level and location in BMDMs treated with DMSO or Yoda1. F) Protein expression of ATF4 in the cytoplasm and nucleus of BMDMs treated with DMSO or Yoda1. G–I) Representative Western blots and quantification of ATF4 and SLC7A11 protein levels in BMDMs after control or Atf4 siRNA transfection and DMSO or Yoda1 treatment (n = 3). J) Flow cytometry analysis of intracellular Ca2+ levels by Fluo-4 staining in BMDMs from Piezo1fl/fl and Piezo1Lyz2 mice treated with DMSO or Yoda1 for 30 min (n = 5 mice per group). K) Fluo-4 fluorescence signals in BMDMs pretreated with 5 µM BAPTA-AM for 24 h followed by DMSO or 5 µm Yoda1 for 30 min were analyzed via flow cytometry (n = 3). L–O) Representative Western blots and quantification of the protein levels of ATF4, SLC7A11 and SLC15A3 in BMDMs (n = 3). The data in (B and D) were analyzed by unpaired Student's t test. Other data were analyzed by one-way ANOVA, followed by the Bonferroni post hoc correction.

2). A novel lncRNA SNHG29 regulates EP300- related histone acetylation modification and inhibits FLT3-ITD AML development. Leukemia, 2023 (PubMed: 37157016) [IF=12.8]

3). Macrophages originated IL-33/ST2 inhibits ferroptosis in endometriosis via the ATF3/SLC7A11 axis. Cell death & disease, 2023 (PubMed: 37816731) [IF=8.1]

4). Transcriptome analysis reveals the efficacy of ginsenoside-Rg1 in the treatment of nonalcoholic fatty liver disease. Life Sciences, 2021 (PubMed: 33385408) [IF=5.2]

Application: WB    Species: rat    Sample: liver tissue

Fig. 5. A) The protein expression levels of ATF3 and ACOX in rat liver of different groups. B) Atf3 relative protein expression level C) Acox2 relative protein expression level (*p < 0.05, **p < 0.01, ***p < 0.001, compare to NAFLD model group, SNK-Q test, n=10).

5). Atf3 + senescent chondrocytes mediate meniscus degeneration in aging. Arthritis research & therapy, 2025 (PubMed: 40375324) [IF=4.9]

Application: IHC    Species: Mouse    Sample:

Fig. 4 The Atf3 + subset identified as a senescent chondrocyte population. (A, B) Gene Ontology(A) enrichment and KEGG analysis(B) for differentially expressed genes in Atf3 + chondrocytes of meniscus. X-axis:–log10(p-value);p 

6). Blocking of FGFR4 signaling by F30 inhibits hepatocellular carcinoma cell proliferation through HMOX1-dependent ferroptosis pathway. European journal of pharmacology, 2024 (PubMed: 38484925) [IF=4.2]

7). Proteotranscriptomics Analysis Reveals the Key Pathways and Genes Involved in Apigenin's Anti-Liver Fibrosis Effects. Journal of proteome research, 2025 (PubMed: 40397522) [IF=3.8]

8). Src-IL-18 signaling regulates the secretion of atrial natriuretic factor in hypoxic beating rat atria. Kardiologia Polska, 2021 (PubMed: 34176112) [IF=3.7]

9). ATF3 suppresses 3T3-L1 adipocyte adipogenesis by transcriptionally repressing USP53. Journal of molecular endocrinology, 2025 (PubMed: 39641389) [IF=3.6]

10). A novel finding relates to the involvement of ATF3/DOCK8 in Alzheimer's disease pathogenesis. Journal of Alzheimer's disease : JAD, 2025 (PubMed: 40267290) [IF=3.4]

加载更多

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.